Determinant of Post COVID-19 Vaccination (Sinovac) Adverse Events Among Health Care Workers in Palembang
Abstract
The COVID-19 cases in Palembang are still increasing every day. This pandemic has forced the adaptation of the "New Normal" lifestyle, which will have an impact on communicable and non-communicable diseases. The Sinovac vaccine used in the COVID-19 vaccination program for Health Care Workers (HCW), which is a top priority, is still a new vaccine, so a survey of complaints and the determinant is important. This study aimed to survey complaints and the determinant of Post COVID-19 Vaccination (Sinovac) Adverse Events among HCW. A cross-sectional study was conducted in Palembang between June and August 2021 on 414 HCWs who received the COVID-19 vaccine injection. The instrument consisted of demographic characteristics, marital status, distance to health care facilities, Body Mass Index (BMI), diet, sleep quality, anxiety, and some medical histories. Overall, although many, all complaints were classified as mild. There was a significant relationship between age, anxiety, and history of food allergy with Post COVID-19 Vaccination Adverse Events (p-value = 0.003; 0.017; 0.050), and anxiety was the determinant of the adverse events (p-value < 0.05). However, there was a significant relationship between age, anxiety, and history of food allergy with Post COVID-19 Vaccination Adverse Events indicates that these factors need to be considered in determining the standard operational procedure for the next vaccination. While there was no significant relationship between obesity, diet, sleep quality, history of drug allergy, atopic disease, hypertension, and dyspepsia syndrome are expected to increase public knowledge and confidence so there will be no worries about receiving the vaccine.
Full text article
Authors
Authors who publish with Jurnal Ilmu Kesehatan Masyarakat (JIKM) agree to the following conditions:
- The author retains the copyright and gives the editorial board the first right to be published with work that is simultaneously licensed under the Creative Commons Linking License that allows others to share (copy and redistribute) material in the media or format an adaptation of the work for any purpose.
- Authors can enter into separate additional contractual arrangements for the non-exclusive distribution of published journal works (for example, posting them to institutional repositories or publishing them in books), with recognition of the initial publication of this journal.